Use of Clomiphene and Luteinizing Hormone/Follicle Stimulating Hormone-releasing Hormone in Investigation of Ovulatory Failure

11Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

A luteinizing hormone/follicle-stimulating hormone-releasing hormone (LH/FSH-RH) test was performed in 70 women with amenorrhoea or anovulatory infertility, or both, and a clomiphene stimulation test was also performed in 24 of these patients. Most patients responded to LH/FSH-RH with significant increases in LH and FSH. In women with gonadal dysgenesis or premature ovarian failure exaggerated responses were observed after LH/FSH-RH and there was no change in high basal LH levels after clomiphene. Patients with absent or impaired responses to LH/FSH-RH failed to respond to clomiphene. All patients with anovulatory menstrual cycles responded to both LH/FSH-RH and clomiphene, while seven out of 13 amenorrhoeic patients with a normal LH/FSH-RH response showed an early LH rise during clomiphene treatment and six were unresponsive. These results suggest a difference between the two groups at hypothalamic level with consequent therapeutic implications. © 1975, British Medical Journal Publishing Group. All rights reserved.

Cite

CITATION STYLE

APA

Ginsburg, J., Isaacs, A. J., Gore, M. B., & Havard, C. W. (1975). Use of Clomiphene and Luteinizing Hormone/Follicle Stimulating Hormone-releasing Hormone in Investigation of Ovulatory Failure. British Medical Journal, 3(5976), 130–133. https://doi.org/10.1136/bmj.3.5976.130

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free